These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23434518)

  • 21. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.
    Mercier F; Boulassel MR; Yassine-Diab B; Tremblay C; Bernard NF; Sekaly RP; Routy JP
    Clin Exp Immunol; 2008 Apr; 152(1):72-80. PubMed ID: 18279439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.
    Correa-Rocha R; Lopez-Abente J; Gutierrez C; Pérez-Fernández VA; Prieto-Sánchez A; Moreno-Guillen S; Muñoz-Fernández MÁ; Pion M
    PLoS One; 2018; 13(8):e0203419. PubMed ID: 30161254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients.
    Gutiérrez C; Lopez-Abente J; Pérez-Fernández V; Prieto-Sánchez A; Correa-Rocha R; Moreno-Guillen S; Muñoz-Fernández MÁ; Pion M
    PLoS One; 2019; 14(3):e0213744. PubMed ID: 30917149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells.
    Grützner EM; Hoffmann T; Wolf E; Gersbacher E; Neizert A; Stirner R; Pauli R; Ulmer A; Brust J; Bogner JR; Jaeger H; Draenert R
    Front Immunol; 2018; 9():811. PubMed ID: 29760693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-1-expressing B cells suppress CD4
    Wang X; Wang G; Wang Z; Liu B; Han N; Li J; Lu C; Liu X; Zhang Q; Yang Q; Wang G
    Mol Immunol; 2019 May; 109():20-26. PubMed ID: 30851633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Day CL; Kaufmann DE; Kiepiela P; Brown JA; Moodley ES; Reddy S; Mackey EW; Miller JD; Leslie AJ; DePierres C; Mncube Z; Duraiswamy J; Zhu B; Eichbaum Q; Altfeld M; Wherry EJ; Coovadia HM; Goulder PJ; Klenerman P; Ahmed R; Freeman GJ; Walker BD
    Nature; 2006 Sep; 443(7109):350-4. PubMed ID: 16921384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory B cells correlate with HIV disease progression.
    Jiao Y; Wang X; Zhang T; Sun L; Wang R; Li W; Ji Y; Wu H; Liu C
    Microbiol Immunol; 2014 Aug; 58(8):449-55. PubMed ID: 24947188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients.
    Combadière B; Faure S; Autran B; Debré P; Combadière C
    AIDS; 2003 Jun; 17(9):1279-90. PubMed ID: 12799549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.
    Casetti R; Pinnetti C; Sacchi A; De Simone G; Bordoni V; Cimini E; Tumino N; Besi F; Viola D; Turchi F; Mazzotta V; Antinori A; Martini F; Ammassari A; Agrati C
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):338-344. PubMed ID: 28418988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.
    Perdomo-Celis F; Velilla PA; Taborda NA; Rugeles MT
    PLoS One; 2019; 14(1):e0210540. PubMed ID: 30625227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell analysis of lymphokine imbalance in asymptomatic HIV-1 infection: evidence for a major alteration within the CD8+ T cell subset.
    Sousa AE; Victorino RM
    Clin Exp Immunol; 1998 May; 112(2):294-302. PubMed ID: 9649194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of TLR7 in CD8(+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection.
    Song Y; Zhuang Y; Zhai S; Huang D; Zhang Y; Kang W; Li X; Liu Q; Yu Q; Sun Y
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1287-95. PubMed ID: 19954299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 38. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses.
    Liu J; Zhan W; Kim CJ; Clayton K; Zhao H; Lee E; Cao JC; Ziegler B; Gregor A; Yue FY; Huibner S; MacParland S; Schwartz J; Song HH; Benko E; Gyenes G; Kovacs C; Kaul R; Ostrowski M
    PLoS One; 2014; 9(2):e89236. PubMed ID: 24586620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CD8
    Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
    Front Immunol; 2018; 9():2788. PubMed ID: 30555473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.